Meeting Details - The shareholders' meeting was held on June 25, 2025, in Harbin, Heilongjiang Province [1] - The meeting was convened by the board of directors and chaired by Chairman Fang Tonghua, utilizing both on-site and online voting methods [1] Voting Results - All proposed resolutions were passed with significant majority votes, with A-share votes showing high approval rates, such as 99.9499% for one resolution [1][2] - Specific voting results included: - 509,418,436 votes in favor (99.9499%), 184,400 against (0.0362%), and 71,100 abstentions (0.0139%) for the first resolution [1] - 509,555,936 votes in favor (99.9768%), 50,600 against (0.0099%), and 67,400 abstentions (0.0133%) for the second resolution [1] - 506,748,236 votes in favor (99.4260%), 2,842,400 against (0.5577%), and 83,300 abstentions (0.0163%) for another resolution [1] Legal Compliance - The meeting's convening and voting procedures complied with the Company Law and relevant regulations, ensuring the legality and validity of the proceedings [4]
珍宝岛: 黑龙江珍宝岛药业股份有限公司2024年年度股东大会决议公告